You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucophage Extended Release (GXR)

Showing 1 - 25 of 7,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Beijing (Test GXR, Reference GXR)

Completed
Has Results
  • Healthy
  • Test GXR
  • Reference GXR
  • Beijing, China
    Xuanwu Hospital Capital Medical University
Dec 18, 2019

Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)

Recruiting
  • Healthy
  • Test Glucophage® XR
  • Reference Glucophage® XR
  • Darmstadt, Germany
    Research Site
Aug 10, 2022

Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)

Recruiting
  • Lung Carcinoma
  • Biopsy
  • +4 more
  • Aurora, Colorado
  • +2 more
Jan 28, 2023

Tendinopathy, Chronic Pain, Achilles Tendinopathy Trial in Pittsburgh (Metformin, Placebo)

Not yet recruiting
  • Tendinopathy
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Oct 19, 2023

Low Back Pain Trial in Pittsburgh, Wexford (Metformin, Placebo)

Active, not recruiting
  • Low Back Pain
  • Pittsburgh, Pennsylvania
  • +1 more
Oct 28, 2022

Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)

Completed
  • Healthy
  • Glucophage® XR Test
  • Glucophage® XR Reference
  • Daejeon, Korea, Republic of
    Clinical Trials Center, Chungnam National University Hospital
Mar 30, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Houston, Texas
  • +2 more
Aug 17, 2022

Erythroplakia, Oral Leukoplakia Trial in Canada, United States (Extended Release Metformin Hydrochloride, Placebo

Not yet recruiting
  • Erythroplakia
  • Oral Leukoplakia
  • Biopsy
  • +3 more
  • Tucson, Arizona
  • +9 more
Dec 14, 2022

Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • +20 more
  • Guanfacine Extended Release
  • Placebo
  • Brooklyn, New York
    Maimonides Medical Center
Dec 20, 2022

Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis Trial (Metformin Extended Release Oral Tablet)

Not yet recruiting
  • Plasminogen Activator Inhibitor-1 Deficiency
  • Cardiac Fibrosis
  • Metformin Extended Release Oral Tablet
  • (no location specified)
Aug 1, 2022

Prostate Cancer, Prostate Cancer Recurrent Trial in Mineola (Metformin Hydrochloride Extended Release 750mg)

Completed
  • Prostate Cancer
  • Prostate Cancer Recurrent
  • Metformin Hydrochloride Extended Release 750mg
  • Mineola, New York
    Winthrop University Hospital
Feb 2, 2022

Prader-Willi Syndrome Trial in New York (Placebo, Guanfacine extended release (GXR))

Withdrawn
  • Prader-Willi Syndrome
  • Placebo
  • Guanfacine extended release (GXR)
  • New York, New York
    NYU Langone Health
Aug 24, 2020

Aging, Insulin Sensitivity, Chronic Disease Trial in Oklahoma City, Madison (Metformin, Placebo oral tablet)

Recruiting
  • Aging
  • +4 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 16, 2021

ADHD Trial in New York (Guanfacine, Lisdexamfetamine)

Terminated
Has Results
  • Attention Deficit Hyperactivity Disorder
  • New York, New York
    New York State Psychiatric Institute
Jan 18, 2023

Head and Neck Squamous Cell Carcinoma Trial in Cincinnati (Metformin Extended Release Oral Tablet, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Sep 15, 2021

ADHD Trial in London (Lisdexamfetamine dimesylate, Guanfacine Extended Release Oral Tablet, Placebo)

Active, not recruiting
  • ADHD
  • Lisdexamfetamine dimesylate
  • +2 more
  • London, United Kingdom
    Institute of Psychiatry, Psychology & Neuroscience; King's Colle
Aug 16, 2022

Drug Use Trial in Jakarta Pusat (Metformin Hydrochloride 500 MG)

Completed
  • Drug Use
  • Metformin Hydrochloride 500 MG
  • Jakarta Pusat, DKI Jakarta, Indonesia
    PT Pharma Metric Labs
Feb 21, 2023

Healthy Trial in Jakarta (Glucophage XR (Test drug), Glucophage XR (Comparator drug))

Completed
Has Results
  • Healthy
  • Glucophage XR (Test drug)
  • Glucophage XR (Comparator drug)
  • Jakarta, Indonesia
    PT Equilab International
Nov 5, 2019

Opioid Use Disorder Trial (Buprenorphine Extended-Release Injection)

Not yet recruiting
  • Opioid Use Disorder
  • Buprenorphine Extended-Release Injection
  • (no location specified)
Feb 2, 2023

ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • ADHD
  • Methylphenidate Hydrochloride Extended Release Capsule
  • Placebo
  • Irvine, California
    University of California, Irvine/Child Development Center
Nov 16, 2022

Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with

Not yet recruiting
  • Cannabis Use Disorder
  • Guanfacine Extended Release Oral Tablet
  • +3 more
  • Parkville, Victoria, Australia
    Orygen
Jul 16, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023